312
Views
32
CrossRef citations to date
0
Altmetric
Review

Stroke in pregnant and postpartum women

, &
Pages 1235-1247 | Published online: 10 Jan 2014

References

  • Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol. Clin.10(1), 113–124 (1992).
  • Di Carlo A, Lamassa M, Consoli D et al. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology75(7), 670–671; author reply 671 (2010).
  • Benedetto C, Marozio L, Tavella AM, Salton L, Grivon S, Di Giampaolo F. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann. NY Acad. Sci.1205(1), 106–117 (2010).
  • Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J. Neurol.245(6–7), 305–313 (1998).
  • Simolke GA, Cox SM, Cunningham FG. Cerebrovascular accidents complicating pregnancy and the puerperium. Obstet. Gynecol.78(1), 37–42 (1991).
  • Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery27(6), 855–865; discussion 865–866 (1990).
  • Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke31(6), 1274–1282 (2000).
  • Kittner SJ, Stern BJ, Feeser BR et al. Pregnancy and the risk of stroke. N. Engl. J. Med.335(11), 768–774 (1996).
  • Witlin AG, Mattar F, Sibai BM. Postpartum stroke: a twenty-year experience. Am. J. Obstet. Gynecol.183(1), 83–88 (2000).
  • James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet. Gynecol.106(3), 509–516 (1997).
  • Lanska DJ, Kryscio RJ. Peripartum stroke and intracranial venous thrombosis in the National Hospital Discharge Survey. Obstet. Gynecol.89(3), 413–418 (2005) .
  • Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke26(6), 930–936 (1995).
  • Jaigobin C, Silver FL. Stroke and pregnancy. Stroke31(12), 2948–2951 (2000).
  • Ros HS, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified? Am. J. Obstet. Gynecol.186(2), 198–203 (2002).
  • Kirkpatrick HF, Robertson JD. Hormonal changes in pregnancy. Med. Illus.7(7), 553–555 (1953).
  • Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur. J. Obstet. Gynecol. Reprod. Biol.73(1), 31–36 (1997).
  • Grandone E, Margaglione M, Colaizzo D et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am. J. Obstet. Gynecol.179(5), 1324–1328 (1998).
  • Dilley A, Austin H, El-Jamil M et al. Genetic factors associated with thrombosis in pregnancy in a USA population. Am. J. Obstet. Gynecol.183(5), 1271–1277 (2000).
  • Gerhardt A, Scharf RE, Beckmann MW et al. Prothrombin and Factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl J. Med.342(6), 374–380 (2000).
  • Robertson L, Wu O, Langhorne P et al. Thrombophilia in pregnancy: a systematic review. Br. J. Haematol.132(2), 171–196 (2006).
  • Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet376(9751), 1498–1509 (2010).
  • Saigal R, Kansal A, Mittal M, Singh Y, Ram H. Antiphospholipid antibody syndrome. J. Assoc. Phys. Ind.58, 176–184 (2010).
  • Honig A, Engel JB, Segerer SE, Kranke P, Hausler S, Wurfel W. Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages. Hum. Reprod.25(11), 2753–2754 (2010).
  • Clark EA, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr. Rheumatol. Rep.9(3), 219–225 (2007).
  • Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am. J. Obstet. Gynecol.169(6), 1382–1392 (1993).
  • Clark SL, Cotton DB, Lee W et al. Central hemodynamic assessment of normal term pregnancy. Am. J. Obstet. Gynecol.161(6 Pt 1), 1439–1442 (1989).
  • Beilin Y. Anesthesia for nonobstetric surgery during pregnancy. Mt. Sinai. J. Med.65(4), 265–270 (1998).
  • Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc. Dis.18(4), 290–295 (2004).
  • ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet.77(1), 67–75 (2002).
  • Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am. J. Obstet. Gynecol.181(4), 924–928 (1999).
  • Sibai BM, Anderson GD, Abdella TN, McCubbin JH, Dilts PV Jr. Eclampsia. III. Neonatal outcome, growth, and development. Am. J. Obstet. Gynecol.146(3), 307–316 (1983).
  • Cunningham FG, Twickler D. Cerebral edema complicating eclampsia. Am. J. Obstet. Gynecol.182(1 Pt 1), 94–100 (2000).
  • Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension38(3 Pt 2), 718–722 (2001).
  • Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med.350(7), 672–683 (2004).
  • Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am. J. Obstet. Gynecol.194(4), 1034–1041 (2006).
  • Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin. Obstet. Gynecol.48(2), 372–386 (2005).
  • Roberts JM. Endothelial dysfunction in preeclampsia. Semin. Reprod. Endocrinol.16(1), 5–15 (1998).
  • Aneesh B, Singhal WJK, Caplan LR. Uncommon Causes of Stroke. Cambridge University Press, Cambridge, UK (2008).
  • Euser AG, Cipolla MJ. Cerebral blood flow autoregulation and edema formation during pregnancy in anesthetized rats. Hypertension49(2), 334–340 (2007).
  • Sheehan HL, Lynch JB. Pathology of Toxemia of Pregnancy. Churchill Livingstone, London, UK (1973).
  • Dirge MV, Caplan LR. Uncommon Causes of Stroke. Cambridge University Press, Cambridge, UK (2008).
  • Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med.334(8), 494–500 (1996).
  • Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistoia L, Rizzuto N. Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta Neurol. Scand.96(5), 277–282 (1997).
  • Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am. J. Obstet. Gynecol.167(4 Pt 1), 935–941 (1992).
  • Demirtas O, Gelal F, Vidinli BD, Demirtas LO, Uluc E, Baloglu A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn. Interv. Radiol.11(4), 189–194 (2005).
  • Digre KB, Varner MW, Osborn AG, Crawford S. Cranial magnetic resonance imaging in severe preeclampsia vs eclampsia. Arch. Neurol.50(4), 399–406 (1993).
  • Raps EC, Galetta SL, Broderick M, Atlas SW. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann. Neurol.33(2), 222–225 (1993).
  • Sengar AR, Gupta RK, Dhanuka AK, Roy R, Das K. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am. J. Neuroradiol.18(8), 1485–1490 (1997).
  • Schwartz RB, Feske SK, Polak JF et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology217(2), 371–376 (2000).
  • Ahn KJ, You WJ, Jeong SL et al. Atypical manifestations of reversible posterior leukoencephalopathy syndrome: findings on diffusion imaging and ADC mapping. Neuroradiology46(12), 978–983 (2004).
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med.333(4), 201–205 (1995).
  • Vigil-De Gracia P, Lasso M, Ruiz E, Vega-Malek JC, de Mena FT, Lopez JC. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. Eur. J. Obstet. Gynecol. Reprod. Biol.128(1–2), 157–162 (2006).
  • Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst. Rev.2, CD004659 (2007).
  • Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ341, c2207 (2007).
  • Martin JN, Jr., Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet. Gynecol.105(2), 246–254 (2005).
  • Somoye G, Samyraju M, Thorpe J, Sriemevan A. Diagnosing postpartum cerebral angiopathy. J. Obstet. Gynaecol.29(3), 248–249 (2009).
  • Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke19(9), 1159–1170 (1988).
  • Chartier JP, Bousigue JY, Teisseyre A, Morel C, Delpuech-Formosa F. [Postpartum cerebral angiopathy of iatrogenic origin]. Rev. Neurol.153(3), 212–214 (1997).
  • Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann. Intern. Med.146(1), 34–44 (2007).
  • Amos P. Postpartum cerebral angiopathy: a case study. J. Neurosci. Nurs.39(1), 9–12 (2007).
  • Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain130(Pt 12), 3091–3101 (2007).
  • Williams TL, Lukovits TG, Harris BT, Harker Rhodes C. A fatal case of postpartum cerebral angiopathy with literature review. Arch. Gynecol. Obstet.275(1), 67–77 (2007).
  • Bogousslavsky J, Despland PA, Regli F, Dubuis PY. Postpartum cerebral angiopathy: reversible vasoconstriction assessed by transcranial Doppler ultrasounds. Eur. Neurol.29(2), 102–105 (1989).
  • Ursell MR, Marras CL, Farb R, Rowed DW, Black SE, Perry JR. Recurrent intracranial hemorrhage due to postpartum cerebral angiopathy: implications for management. Stroke29(9), 1995–1998 (1998).
  • Zunker P, Golombeck K, Brossmann J, Georgiadis D, Deuschl G. Post-partum cerebral angiopathy: repetitive TCD, MRI, MRA, and EEG examinations. Neurol. Res.24(6), 570–572 (2002).
  • Gomez CR, Gomez SM, Puricelli MS, Malik mm. Transcranial Doppler in reversible migrainous vasospasm causing cerebellar infarction: report of a case. Angiology42(2), 152–156 (1991).
  • Ihara M, Yanagihara C, Nishimura Y. Serial transcranial color-coded sonography in postpartum cerebral angiopathy. J. Neuroimag.10(4), 230–233 (2000).
  • Singhal AB, Bernstein RA. Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit. Care3(1), 91–97 (2005).
  • Boughammoura A, Touze E, Oppenheim C, Trystram D, Mas JL. Reversible angiopathy and encephalopathy after blood transfusion. J. Neurol.250(1), 116–118 (2003).
  • Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch. Neurol.61(3), 411–416 (2004).
  • Klein M, Fesl G, Pfister HW et al. Intra-arterial nimodipine in progressive postpartum cerebral angiopathy. Cephalalgia29(2), 279–282 (2009).
  • Lu SR, Liao YC, Fuh JL, Lirng JF, Wang SJ. Nimodipine for treatment of primary thunderclap headache. Neurology62(8), 1414–1416 (2004).
  • Akins PT, Levy KJ, Cross AH, Goldberg MP, Schieber MH. Postpartum cerebral vasospasm treated with hypervolemic therapy. Am. J. Obstet. Gynecol.175(5), 1386–1388 (1996).
  • Song JK, Fisher S, Seifert TD et al. Postpartum cerebral angiopathy: atypical features and treatment with intracranial balloon angioplasty. Neuroradiology46(12), 1022–1026 (2004).
  • Abercrombie J. Pathological and Practical Researches on Disease of the Brain and Spinal Cord. Waugh and Innes, Edinburgh, UK (1828).
  • Collier W. Thrombosis of cerebral veins. Lancet1, 544 (1891).
  • Banerjee AK, Varma M, Vasista RK, Chopra JS. Cerebrovascular disease in north-west India: a study of necropsy material. J. Neurol. Neurosurg. Psychiatry52(4), 512–515 (1989).
  • Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet344(8939–8940), 1739–1742 (1994).
  • Daniel DG. Estrogens and puerperal thrombembolism. Am. Heart J.78(5), 720–722 (1969).
  • Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood60(1), 261–264 (1982).
  • Bonnar J, Davidson JF, Pidgeon CF, McNicol GP, Douglas AS. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br. Med. J.3(5663), 137–140 (1969).
  • Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CR. Development of resistance to activated protein C during pregnancy. Br. J. Haematol.90(3), 725–727 (1995).
  • Hellgren M, Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am. J. Obstet. Gynecol.173(1), 210–213 (1995).
  • Vasse M, Leduc O, Borg JY, Chretien MH, Monconduit M. Resistance to activated protein C: evaluation of three functional assays. Thromb. Res.76(1), 47–59 (1994).
  • Syrjanen J, Peltola J, Valtonen V, Iivanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle-aged men. J. Intern. Med.225(3), 179–184 (1989).
  • Syrjanen J, Valtonen VV, Iivanainen M, Hovi T, Malkamaki M, Makela PH. Association between cerebral infarction and increased serum bacterial antibody levels in young adults. Acta Neurol. Scand.73(3), 273–278 (1986).
  • Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke27(11), 1999–2004 (1996).
  • Bousser MG. Cerebral venous thrombosis: diagnosis and management. J. Neurol.247(4), 252–258 (2000).
  • Terazzi E, Mittino D, Ruda R et al. Cerebral venous thrombosis: a retrospective multicentre study of 48 patients. Neurol. Sci.25(6), 311–315 (2005).
  • Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol. Clin.10(1), 87–111 (1992).
  • Casey SO, Alberico RA, Patel M et al. Cerebral CT venography. Radiology198(1), 163–170 (1996).
  • Diaz JM, Schiffman JS, Urban ES, Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol. Scand.86(4), 390–396 (1992).
  • Einhaupl KM, Villringer A, Meister W et al. Heparin treatment in sinus venous thrombosis. Lancet338(8767), 597–600 (1991).
  • de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke30(3), 484–488 (1999).
  • Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke30(3), 481–483 (1999).
  • Habli M, O’Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am. J. Obstet. Gynecol.199(4), 415.e1–e5 (2008).
  • Leys D, Lamy C, Lucas C et al. Arterial ischemic strokes associated with pregnancy and puerperium. Acta Neurol. Belg.97(1), 5–16 (1997).
  • Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology55(2), 269–274 (2000).
  • Pearson GD, Veille JC, Rahimtoola S et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA283(9), 1183–1188 (2000).
  • Abenhaim HA, Azoulay L, Kramer MS, Leduc L. Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the USA. Am. J. Obstet. Gynecol.199(1), 49.e1–e8 (2008).
  • Knight M. Amniotic fluid embolism: active surveillance versus retrospective database review. Am. J. Obstet. Gynecol.199(4), e9 (2008).
  • Talbert LM, Adcock DF, Weiss AE, Easterling WE, Jr., Odom MH. Studies on the pathogenesis of clotting defects during salt-induced abortions. Am. J. Obstet. Gynecol.115(5), 656–662 (1973).
  • Masson RG, Ruggieri J, Siddiqui MM. Amniotic fluid embolism: definitive diagnosis in a survivor. Am. Rev. Respir. Dis.120(1), 187–192 (1979).
  • Bastien JL, Graves JR, Bailey S. Atypical presentation of amniotic fluid embolism. Anesth. Analg.87(1), 124–126 (1998).
  • Courtney LD. Amniotic fluid embolism. Br. Med. J.1(5695), 545 (1970).
  • Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based review. Am. J. Obstet. Gynecol.201(5), 44.e1–e13 (2009).
  • Fox MW, Harms RW, Davis DH. Selected neurologic complications of pregnancy. Mayo Clin. Proc.65(12), 1595–1618 (1990).
  • Weir B, MacDonald N, Mielke B. Intracranial vascular complications of choriocarcinoma. Neurosurgery2(2), 138–142 (1978).
  • Giannakopoulos G, Nair S, Snider C, Amenta PS. Implications for the pathogenesis of aneurysm formation: metastatic choriocarcinoma with spontaneous splenic rupture. Case report and a review. Surg. Neurol.38(3), 236–240 (1992).
  • Van de Kelft E, Kunnen J, Truyen L, Heytens L. Postpartum dissecting aneurysm of the basilar artery. Stroke23(1), 114–116 (1992).
  • Bruninx G, Roland H, Matte JC, Magermans H, Jacquy J, Delcour C. [Carotid dissection during childbirth]. J. Mal. Vasc.21(2), 92–94 (1996).
  • Waidelich JM, Bullough AS, Mhyre JM. Internal carotid artery dissection: an unusual cause of postpartum headache. Int. J. Obstet. Anesth.17(1), 61–65 (2008).
  • Gould DB, Cunningham K. Internal carotid artery dissection after remote surgery. Iatrogenic complications of anesthesia. Stroke25(6), 1276–1278 (1994).
  • Cacciotti L, Camastra GS, Ansalone G. Atrial fibrillation in a pregnant woman with a normal heart. Intern. Emerg. Med.5(1), 87–88 (2010).
  • Sawhney H, Aggarwal N, Suri V, Vasishta K, Sharma Y, Grover A. Maternal and perinatal outcome in rheumatic heart disease. Int. J. Gynaecol. Obstet.80(1), 9–14 (2003).
  • Bhatla N, Lal S, Behera G et al. Cardiac disease in pregnancy. Int. J. Gynaecol. Obstet.82(2), 153–159 (2003).
  • Connolly JO, Lanham JG, Partridge MR. Fulminant pregnancy-related Churg–Strauss syndrome. Br. J. Rheumatol.33(8), 776–777 (1994).
  • Doria A, Bajocchi G, Tonon M, Salvarani C. Prepregnancy counselling of patients with vasculitis. Rheumatology47(Suppl. 3iii), 13–15 (2008).
  • Hiyama J, Shiota Y, Marukawa M et al. Churg-Strauss syndrome associated with pregnancy. Intern. Med.39(11), 985–990 (2000).
  • Cines DB, Pollak ES, Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood91(10), 3527–3561 (1998).
  • Hassell K. Pregnancy and sickle cell disease. Hematol. Oncol. Clin. North Am.19(5), 903–916 (2005).
  • Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ338, b664 (2009).
  • Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology68(19), 1563–1570 (2007).
  • Henry PY, Larre P, Aupy M, Lafforgue JL, Orgogozo JM. Reversible cerebral arteriopathy associated with the administration of ergot derivatives. Cephalalgia4(3), 171–178 (1984).
  • Allais G, Gabellari IC, Borgogno P, De Lorenzo C, Benedetto C. The risks of women with migraine during pregnancy. Neurol. Sci.31(Suppl. 1), S59–S61 (2010).
  • Rotton WN, Sachtleben MR, Friedman EA. Migraine and eclampsia. Obstet. Gynecol.14, 322–330 (1959).
  • Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad. Med. J.54(628), 98–102 (1978).
  • Moore MP, Redman CW. Case-control study of severe pre-eclampsia of early onset. Br. Med. J.287(6392), 580–583 (1983).
  • Marcoux S, Berube S, Brisson C, Mondor M. Job strain and pregnancy-induced hypertension. Epidemiology10(4), 376–382 (1999).
  • Chen TC, Leviton A. Headache recurrence in pregnant women with migraine. Headache34(2), 107–110 (1994).
  • D’Amico D, Moschiano F, Leone M et al. Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia18(9), 618–621 discussion 591 (1998).
  • Crassard I, Conard J, Bousser MG. Migraine and haemostasis. Cephalalgia21(6), 630–636 (2001).
  • Schurks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology71(7), 505–513 (2008).
  • Treadwell SD, Thanvi B, Robinson TG. Stroke in pregnancy and the puerperium. Postgrad. Med. J.84(991), 238–245 (2008).
  • Guidelines for diagnostic imaging during pregnancy. The American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet.51(3), 288–291 (1995).
  • Bourjeily G, Chalhoub M, Phornphutkul C, Alleyne TC, Woodfield CA, Chen KK. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology256(3), 744–750 (2010).
  • Ahmet A, Lawson ML, Babyn P, Tricco AC. Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatr.98(10), 1568–1574 (2009).
  • Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur. Radiol.15(6), 1234–1240 (2005).
  • Garden AS, Griffiths RD, Weindling AM, Martin PA. Fast-scan magnetic resonance imaging in fetal visualization. Am. J. Obstet. Gynecol.164(5 Pt 1), 1190–1196 (1991).
  • Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology232(3), 635–652 (2004).
  • Levine D. Obstetric MRI. J. Magn. Reson. Imaging24(1), 1–15 (2006).
  • Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J. Magn. Reson. Imaging10(3), 477–484 (1999).
  • CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet343(8898), 619–629 (1994).
  • Tiboni GM, Iammarrone E, Piccirillo G, Liberati M, Bellati U. Aspirin pretreatment potentiates hyperthermia-induced teratogenesis in the mouse. Am. J. Obstet. Gynecol.178(2), 270–279 (1998).
  • Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA266(2), 260–264 (1991).
  • Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ314(7076), 253–257 (1997).
  • Kutteh WH. Antiphospholipid antibodies and reproduction. J. Reprod. Immunol.35(2), 151–171 (1997).
  • Nassar AH, Hobeika EM, Abd Essamad HM, Taher A, Khalil AM, Usta IM. Pregnancy outcome in women with prosthetic heart valves. Am. J. Obstet. Gynecol.191(3), 1009–1013 (2004).
  • Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch. Intern. Med.160(2), 191–196 (2000).
  • James AH, Grotegut CA, Brancazio LR, Brown H. Thromboembolism in pregnancy: recurrence and its prevention. Semin. Perinatol.31(3), 167–175 (2007).
  • Dahlman TC, Sjoberg HE, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am. J. Obstet. Gynecol.170(5 Pt 1), 1315–1320 (1994).
  • Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R. Heparin therapy during pregnancy. Risks to the fetus and mother. Arch. Intern. Med.149(10), 2233–2236 (1989).
  • Cronin CA, Weisman CJ, Llinas RH. Stroke treatment: beyond the three-hour window and in the pregnant patient. Ann. NY Acad. Sci.1142, 159–178 (2008).
  • Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA282(21), 2003–2011 (1999).
  • Davis S, Donnan G. The ECASS III results and the tPA paradox. Int. J. Stroke4(1), 17–18 (2009).
  • Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke35(4), 904–911 (2004).
  • Smith WS, Sung G, Saver J et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke39(4), 1205–1212 (2008).
  • Holden EL, Ranu H, Sheth A, Shannon MS, Madden BP. Thrombolysis for massive pulmonary embolism in pregnancy – a report of three cases and follow up over a two year period. Thromb. Res.127(1), 58–59 (2011).
  • Biteker M, Duran NE, Ozkan M. Successful treatment of massive pulmonary embolism in a pregnant woman, with low-dose, slow infusion of tissue plasminogen activator. Turk. Kardiyol. Dern. Ars.38(1), 32–34 (2010).
  • Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options. Arch. Intern. Med.162(11), 1221–1227 (2002).
  • Bechtel JJ, Mountford MC, Ellinwood WE. Massive pulmonary embolism in pregnancy treated with catheter fragmentation and local thrombolysis. Obstet. Gynecol.106(5 Pt 2), 1158–1160 (2005).
  • Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke36(6), e53–e55 (2005).
  • Murugappan A, Coplin WM, Al-Sadat AN et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology66(5), 768–770 (2006).
  • Elford K, Leader A, Wee R, Stys PK. Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology59(8), 1270–1272 (2002).
  • Mendez JC, Masjuan J, Garcia N, de Lecinana M. Successful intra-arterial thrombolysis for acute ischemic stroke in the immediate postpartum period: case report. Cardiovasc. Intervent. Radiol.31(1), 193–195 (2008).
  • Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet. Gynecol. Surv.50(7), 534–541 (1995).
  • Aleu A, Mellado P, Lichy C, Kohrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke38(2), 417–422 (2007).
  • Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke37(8), 2168–2169 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.